FBI Launches Investigation into Late Colts Owner's Ketamine and Drug Use
The Federal Bureau of Investigation has initiated a formal inquiry into the circumstances surrounding the death of former Indianapolis Colts owner Jim Irsay, who passed away last May at the age of 65. According to a new report from The Washington Post, the investigation centres on Irsay's use of ketamine and other substances, as well as his relationship with a prominent addiction specialist.
Grand Jury Subpoena Reveals Scope of Probe
The FBI has reportedly issued a federal grand jury subpoena requesting comprehensive information related to Irsay's death, his documented use of both illegal and prescription substances, and his professional association with Dr. Harry Haroutunian. The addiction specialist is alleged to have provided Irsay with drugs in the months leading up to his passing. While the FBI has declined to confirm the investigation to The Independent, citing standard agency policy, the subpoena indicates a serious federal examination of the matter.
Contradictions in the Official Narrative
Irsay, who had been open about his long-standing struggles with drug and alcohol addiction throughout his life, was initially reported by the Colts organisation to have "passed away peacefully in his sleep". However, subsequent reporting has revealed a more complex picture. The NFL executive had experienced significant health challenges following a serious fall at his home in December 2023, which was followed by treatment for a severe respiratory illness in early 2024.
Despite public statements about his recovery from two surgeries during the summer of 2024, The Washington Post uncovered evidence suggesting Irsay had secretly relapsed. The publication reported that he was receiving ketamine injections and opioid pills from Dr. Haroutunian during the final months of his life.
Evidence of Multiple Overdoses Emerges
Further disturbing details have emerged regarding Irsay's condition prior to his death. Investigative reporting indicates that the Colts owner suffered from two separate drug overdoses within a remarkably short timeframe. The first incident occurred in December 2023 at his Indianapolis residence, followed by another overdose just twelve days later at a luxury resort near Miami.
Dr. Haroutunian, when contacted by The Washington Post about his relationship with Irsay, described the late football executive as a "brother" and stated he had dedicated eighteen months to providing care. "We did everything we could to make him as comfortable as possible," Haroutunian commented in the summer report.
Broader Context of Celebrity Drug Investigations
This investigation into Irsay's death follows a pattern of increased federal scrutiny regarding drug-related fatalities among high-profile individuals. Notably, five people were recently charged in connection with the fatal ketamine overdose of Friends star Matthew Perry. In that case, two medical professionals who provided ketamine to Perry pleaded guilty to related charges and received subsequent sentences.
The FBI's examination of Jim Irsay's final months represents a significant development in understanding the circumstances surrounding the death of one of the NFL's most prominent figures. As the investigation progresses, further details may emerge about the complex interplay between addiction treatment, prescription practices, and celebrity healthcare.
